[Federal Register Volume 60, Number 182 (Wednesday, September 20, 1995)]
[Notices]
[Pages 48715-48716]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-23249]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 95F-0221]
DuCoa L.P.; Filing of Food Additive Petition (Animal Use)
Natamycin
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that
DuCoa L.P. has filed a petition proposing that the food additive
regulations be amended to provide for the safe use of natamycin as a
mold retardant of Aspergillus parasiticus, Penicillium rubrum, and
Fusarium moniliforme in broiler chicken feed for up to 14 days when
used at a level of 11 parts per million (ppm).
DATES: Written comments on the petitioner's environmental assessment by
November 20, 1995.
ADDRESSES: Submit written comments to the Dockets Management Branch
(HFA-305), Food and Drug Administration, rm. 1-23, 12420 Parklawn Dr.,
Rockville, MD 20857.
FOR FURTHER INFORMATION CONTACT: Sharon A. Benz, Center for Veterinary
Medicine (HFV-226), Food and Drug Administration, 7500 Standish Pl.,
Rockville, MD 20855, 301-594-1724.
SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic
Act (sec. 409(b)(5) (21 U.S.C. 348(b)(5))), notice is given that a food
additive petition (FAP 2234) has been filed by DuCoa L.P., Technical
Products Division, P.O. Box 219, Highland, IL 62249-0219. The petition
proposes to amend the food additive regulations in part 573 Food
Additives Permitted in Feed and Drinking Water of Animals (21 CFR part
573) to provide for the safe use of natamycin as a mold retardant of A.
parasiticus, P. rubrum, and F. moniliforme for up to 14 days in broiler
chicken feed when used at a level of 11 ppm.
The potential environmental impact of this action is being
reviewed. To encourage public participation consistent with regulations
promulgated
[[Page 48716]]
under the National Environmental Policy Act (40 CFR 1501.4(b)), the
agency is placing the environmental assessment submitted with the
petition that is the subject of this notice on public display at the
Dockets Management Branch (address above) for public review and
comment. Interested persons may, on or before November 20, 1995, submit
to the Dockets Management Branch (address above) written comments. Two
copies of any comments are to be submitted, except that individuals may
submit one copy. Comments are to be identified with the docket number
found in brackets in the heading of this document. Received comments
may be seen in the office above between 9 a.m. and 4 p.m., Monday
through Friday. FDA will also place on public display any amendments
to, or comments on, the petitioner's environmental assessment without
further announcement in the Federal Register. If, based on its review,
the agency finds that an environmental impact statement is not required
and this petition results in a regulation, the notice of availability
of the agency's findings of no significant impact and the evidence
supporting that finding will be published with the regulation in the
Federal Register in accordance with 21 CFR 25.40(c).
Dated: September 7, 1995.
Stephen F. Sundlof,
Director, Center for Veterinary Medicine.
[FR Doc. 95-23249 Filed 9-19-95; 8:45 am]
BILLING CODE 4160-01-F
